<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00171782</url>
  </required_header>
  <id_info>
    <org_study_id>CVAH631BCO02</org_study_id>
    <nct_id>NCT00171782</nct_id>
  </id_info>
  <brief_title>Hypertension and Cardiovascular Risk Factors</brief_title>
  <official_title>Valsartan Plus Hydrochlorothiazide in Patients With Hypertension and Cardiovascular Risk Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <brief_summary>
    <textblock>
      A study to evaluate the efficacy of valsartan+chydochlorothiazide in patients with stage 2
      hypertension and cardiovascular risk factors.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2004</start_date>
  <completion_date type="Actual">December 2004</completion_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline systolic blood pressure at 8 weeks</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure less than 140/90 mmHg at 8 weeks</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction from baseline in diastolic blood pressure greater than or equal to 10 mmHg</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction from baseline in systolic blood pressure greater than or equal to 20 mmHg</measure>
  </secondary_outcome>
  <enrollment type="Actual">76</enrollment>
  <condition>HYPERTENSION</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>VALSARTAN+HYDROCHLOROTHIAZIDE</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  - Patients who give consent

          -  Men and women 18 to 80 years of age

          -  Patients with hypertension (systolic &gt;159 mm, diastolic &gt;100 mm)

          -  Patients meeting laboratory criteria

        Exclusion Criteria:

          -  - Pregnant women

          -  Women not using approved contraception methods

          -  Secondary hypertension

        Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Novartis Pharmaceuticals</last_name>
    <role>Study Director</role>
    <affiliation>Novartis Pharmaceuticals</affiliation>
  </overall_official>
  <verification_date>June 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>November 7, 2011</last_update_submitted>
  <last_update_submitted_qc>November 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HYPERTENSION</keyword>
  <keyword>VALSARTAN</keyword>
  <keyword>VALSARTAN AND HYDROCHLOROTHIAZIDE</keyword>
  <keyword>RISK FACTORS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Valsartan</mesh_term>
    <mesh_term>Hydrochlorothiazide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

